glp-1 gastroparesis class action in kentucky semaglutide gastric intestinal obstruction gastrointestinal lawyer attorney kentucky glp-1 legal team semaglutide gastric intestinal obstruction lawsuit

Lglutathione provides the finished molecule

Ingredients & Identity CJC-1295 CAS: 863288-34-0 CJC-1295 MF/MW: C152H252N44O42 / 3367.93 g/mol Ipamorelin CAS: 170851-70-4 Ipamorelin MF/MW: C38H49N9O5 / 711.86 g/mol Mass per vial: 10 mg total combined lyophilizate Form: Lyophilized white powder Compound Lyophilized binary blend of CJC-1295 (Modified GRF 1-29, a 30-amino-acid GHRH analog) and Ipamorelin (synthetic pentapeptide)

All products are intended solely for laboratory research and are not for human or animal consumption

Elrick H, Stimmler L, Hlad CJ, et al

The company's CT-388 dual agonist and CT-996 oral formulation are progressing through Phase II trials, with potential market entry expected by 2029